[Treatment of decubitus ulcer with Crilanomer and dextranomer].
In a clinical study on decubital ulcers, 95 patients in 10 hospitals were treated with dextranomer and crilanomer. The size of the ulcer surface and the physician's evaluation of the healing status at the end of treatment served as the most important criteria for our assessment of the curative effect. Both preparations proved equivalent in the statistical test. Crilanomer revealed slightly better results than dextranomer with regard to the physician's overall evaluation al well as odor, exudation, and cleansing. Both modes of treatment were accompanied by local incompatibility reactions of a minor degree; there were no systemic side effects in either preparation.
Esch
B
B
Behring Krankenhaus, Schering AG, Berlin.
Raptis
G
G
D000181:Acrylonitrile / Q000008:administration & dosage*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003911:Dextrans / Q000008:administration & dosage*; D005260:Female; D005782:Gels; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009570:Nitriles / Q000008:administration & dosage*; D011108:Polymers / Q000008:administration & dosage*; D003668:Pressure Ulcer / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D013213:Starch / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D014945:Wound Healing / Q000187:drug effects
D003911:Dextrans; D005782:Gels; D009570:Nitriles; D011108:Polymers; C013471:dextranomer; C052197:Clinagel; D013213:Starch; C043831:starch polyacrylate; D000181:Acrylonitrile
Therapie von Dekubitus mit Crilanomer und Dextranomer.